David Ubben

1.4k total citations
22 papers, 795 citations indexed

About

David Ubben is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, David Ubben has authored 22 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 7 papers in Computational Theory and Mathematics and 5 papers in Pharmacology. Recurrent topics in David Ubben's work include Malaria Research and Control (18 papers), Computational Drug Discovery Methods (7 papers) and Mosquito-borne diseases and control (7 papers). David Ubben is often cited by papers focused on Malaria Research and Control (18 papers), Computational Drug Discovery Methods (7 papers) and Mosquito-borne diseases and control (7 papers). David Ubben collaborates with scholars based in Switzerland, Italy and United States. David Ubben's co-authors include Nigel S. Cook, Umberto D’Alessandro, Xavier C. Ding, Timothy N. C. Wells, Michael Nambozi, Modest Mulenga, Antonella Bacchieri, Bernhards Ogutu, Oumar Gaye and Michael Makanga and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

David Ubben

22 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ubben Switzerland 16 597 152 111 106 97 22 795
Ronnatrai Rueangweerayut Thailand 12 552 0.9× 142 0.9× 203 1.8× 75 0.7× 148 1.5× 15 761
George Adjei Ghana 19 624 1.0× 70 0.5× 180 1.6× 113 1.1× 86 0.9× 55 914
Retno Gitawati Indonesia 12 650 1.1× 35 0.2× 82 0.7× 68 0.6× 37 0.4× 32 976
Sophie Namasopo Canada 17 409 0.7× 38 0.3× 103 0.9× 69 0.7× 27 0.3× 47 750
Pham Phuong Vietnam 13 455 0.8× 124 0.8× 45 0.4× 60 0.6× 100 1.0× 13 1.1k
K Chalermrut Thailand 15 405 0.7× 102 0.7× 70 0.6× 43 0.4× 125 1.3× 17 481
Xing-Bo Guo China 7 439 0.7× 151 1.0× 14 0.1× 51 0.5× 139 1.4× 12 595
Rianto Setiabudy Indonesia 13 221 0.4× 24 0.2× 108 1.0× 32 0.3× 134 1.4× 78 604
Philip Sasi Tanzania 15 425 0.7× 129 0.8× 105 0.9× 67 0.6× 135 1.4× 36 774
Georgina Humphreys United Kingdom 10 356 0.6× 118 0.8× 20 0.2× 63 0.6× 59 0.6× 15 466

Countries citing papers authored by David Ubben

Since Specialization
Citations

This map shows the geographic impact of David Ubben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ubben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ubben more than expected).

Fields of papers citing papers by David Ubben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ubben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ubben. The network helps show where David Ubben may publish in the future.

Co-authorship network of co-authors of David Ubben

This figure shows the co-authorship network connecting the top 25 collaborators of David Ubben. A scholar is included among the top collaborators of David Ubben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ubben. David Ubben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Funck‐Brentano, Christian, Antonella Bacchieri, Giovanni Valentini, et al.. (2019). Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval Prolongation. Scientific Reports. 9(1). 777–777. 9 indexed citations
2.
Reuter, Stephanie E., Allan M. Evans, Sepehr Shakib, et al.. (2015). Effect of Food on the Pharmacokinetics of Piperaquine and Dihydroartemisinin. Clinical Drug Investigation. 35(9). 559–567. 22 indexed citations
3.
Ceesay, Serign J., Lamine Koivogui, Alain Nahum, et al.. (2015). Malaria Prevalence among Young Infants in Different Transmission Settings, Africa. Emerging infectious diseases. 21(7). 1114–1121. 27 indexed citations
4.
Okell, Lucy, Matthew Cairns, Jamie T. Griffin, et al.. (2014). Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis. Nature Communications. 5(1). 5606–5606. 71 indexed citations
5.
Ubben, David, et al.. (2013). MMV in partnership: the Eurartesim® experience. Malaria Journal. 12(1). 211–211. 18 indexed citations
6.
7.
Longo, Monica, et al.. (2012). Piperaquine phosphate: Reproduction studies. Reproductive Toxicology. 34(4). 584–597. 3 indexed citations
8.
Gargano, Nicola, David Ubben, Antonella Bacchieri, et al.. (2012). Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India. Malaria Journal. 11(1). 233–233. 22 indexed citations
9.
Duparc, Stephan, et al.. (2012). Optimal dose finding for novel antimalarial combination therapy*. Tropical Medicine & International Health. 17(4). 409–413. 5 indexed citations
10.
Ding, Xavier C., David Ubben, & Timothy N. C. Wells. (2012). A framework for assessing the risk of resistance for anti-malarials in development. Malaria Journal. 11(1). 292–292. 48 indexed citations
11.
D’Alessandro, Umberto, David Ubben, Kamal Hamed, et al.. (2012). Malaria in infants aged less than six months - is it an area of unmet medical need?. Malaria Journal. 11(1). 400–400. 59 indexed citations
12.
Nambozi, Michael, Jean‐Pierre Van Geertruyden, Sebastian Hachizovu, et al.. (2011). Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. Malaria Journal. 10(1). 50–50. 47 indexed citations
13.
Bassat, Quique, Raquel González, Sónia Machevo, et al.. (2011). Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges. Malaria Journal. 10(1). 369–369. 13 indexed citations
14.
Kern, Steven E., Alfred B. Tiono, Michael Makanga, et al.. (2011). Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis. Malaria Journal. 10(1). 210–210. 54 indexed citations
15.
Mayxay, Mayfong, Sommay Keomany, Kasia Stepniewska, et al.. (2010). A Phase III, Randomized, Non-Inferiority Trial to Assess the Efficacy and Safety of Dihydroartemisinin-Piperaquine in Comparison with Artesunate-Mefloquine in Patients with Uncomplicated Plasmodium falciparum Malaria in Southern Laos. American Journal of Tropical Medicine and Hygiene. 83(6). 1221–1229. 26 indexed citations
16.
Abdulla, Salim, Mbaraka Amuri, Abdunoor M. Kabanywanyi, et al.. (2010). Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects. Malaria Journal. 9(1). 253–253. 21 indexed citations
17.
Ogutu, Bernhards, Alfred B. Tiono, Michael Makanga, et al.. (2010). Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?. Malaria Journal. 9(1). 30–30. 53 indexed citations
18.
Bassat, Quique, Modest Mulenga, Halidou Tinto, et al.. (2009). Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial. PLoS ONE. 4(11). e7871–e7871. 108 indexed citations
19.
Nwaka, Solomon, Lise Riopel, David Ubben, & J. Carl Craft. (2004). Medicines for Malaria Venture new developments in antimalarials. Travel Medicine and Infectious Disease. 2(3-4). 161–170. 15 indexed citations
20.
Cook, Nigel S. & David Ubben. (1990). Fibrinogen as a major risk factor in cardiovascular disease. Trends in Pharmacological Sciences. 11(11). 444–451. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronnatrai Rueangweerayut Breakdown of academic impact, for papers by George Adjei Breakdown of academic impact, for papers by Retno Gitawati Breakdown of academic impact, for papers by Sophie Namasopo Breakdown of academic impact, for papers by Pham Phuong Breakdown of academic impact, for papers by K Chalermrut Breakdown of academic impact, for papers by Xing-Bo Guo Breakdown of academic impact, for papers by Rianto Setiabudy Breakdown of academic impact, for papers by Philip Sasi Breakdown of academic impact, for papers by Georgina Humphreys
Rankless by CCL
2026